GO:0003713 transcription coactivator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003713 transcription coactivator activity describes a coregulator function that increases transcription of specific gene sets by binding DNA-binding transcription factors at defined genomic loci, either alone or within a complex.
• Coactivators act through four principal routes: covalent histone modification, ATP-dependent chromatin remodeling, modulation of transcription factor-coregulator interactions, and bridging transcription factors to the basal transcription machinery, including the Mediator complex.
• The term is a molecular_function in the Gene Ontology and is distinct from DNA-binding transcription factor activity and from general basal transcription factor activity.
• Functional genomics screens in human cells have identified and characterized many transcriptional activators, providing a systematic map of coactivator-dependent gene regulation.
• Coactivator proteins such as PGC-1 and PGC-1 alpha control mitochondrial biogenesis, respiration, and slow-twitch muscle fiber formation, linking coactivator activity to energy homeostasis.
• Dysregulated coactivator activity contributes to cancer, metabolic disease, and developmental disorders, making these proteins attractive targets for CRISPR-based functional studies.
Description
Transcription coactivator activity (GO:0003713) is a molecular function that defines how coregulatory proteins increase transcription of specific gene sets without themselves binding DNA in a sequence-specific manner. Instead, coactivators are recruited by DNA-binding transcription factors to particular genomic loci, where they activate or enhance transcription either on their own or as part of a larger complex. This activity is central to the logic of regulated transcription because it converts sequence-specific DNA occupancy into productive RNA polymerase II output. Researchers studying gene regulation therefore need to distinguish coactivator activity from DNA-binding transcription factor activity and from general basal transcription machinery functions. The mechanistic repertoire of transcription coactivators is broad. One class modifies chromatin structure through covalent modification of histones, a second remodels chromatin conformation in an ATP-dependent fashion, a third modulates interactions between DNA-bound transcription factors and other coregulators, and a fourth bridges DNA-binding transcription factors to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA-binding transcription factors and RNA polymerase, is itself a transcription coactivator. This diversity means that GO:0003713 captures a functional outcome, increased transcription, rather than a single biochemical reaction. Because coactivators integrate signals from enhancers and super-enhancers, they are critical for cell-type-specific gene expression programs. Systematic identification and functional characterization of transcriptional activators in human cells has revealed many proteins that meet the criteria for coactivator activity, providing a resource for mechanistic and disease studies. Coactivator dysfunction has been linked to cancer, metabolic disorders, and other human diseases, underscoring the importance of precise experimental models for this GO term.
transcription coactivator activity At A Glance
| GO ID | GO:0003713 |
|---|---|
| GO term | transcription coactivator activity |
| Ontology | molecular_function |
| Synonym | RNA polymerase II transcription co-activator activity; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription mediator activity; transcription co-activator activity |
| Major function | Activates or increases transcription of specific gene sets by binding DNA-binding transcription factors at specific genomic loci, alone or in a complex |
| Mechanistic classes | Covalent histone modification; ATP-dependent chromatin remodeling; modulation of transcription factor-coregulator interactions; bridging to basal transcription machinery |
| Example complex | Mediator complex, which bridges sequence-specific DNA-binding transcription factors and RNA polymerase |
| Related activity | Distinct from DNA-binding transcription factor activity and from basal transcription factor activity |
What Is GO:0003713?
In the Gene Ontology, transcription coactivator activity (GO:0003713) is defined as a transcription coregulator activity that activates or increases the transcription of specific gene sets via binding to a DNA-binding transcription factor at a specific genomic locus, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications; for example, one class modifies chromatin structure through covalent modification of histones, a second remodels the conformation of chromatin in an ATP-dependent fashion, a third modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators, and a fourth bridges a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. Synonyms include RNA polymerase II transcription co-activator activity, RNA polymerase II transcription coactivator activity, RNA polymerase II transcription mediator activity, and transcription co-activator activity.
Why Is transcription coactivator activity Important in Cell Biology?
Transcription coactivator activity is important because it is the functional interface through which sequence-specific transcription factors communicate with the chromatin template and the basal transcription machinery to produce appropriate gene expression programs. Coactivators determine the magnitude and specificity of transcriptional responses, and their dysregulation can reprogram cellular states in disease. For example, super-enhancers include classical enhancers and facilitators that cooperate to fully activate gene expression, a process that depends on coactivator recruitment and function. Systematic functional characterization of human transcriptional activators has shown that many coactivators are required for cell fitness and gene activation, making them high-value targets for functional genomics. In metabolic tissues, coactivators such as PGC-1 and PGC-1 alpha control mitochondrial biogenesis, respiration, and muscle fiber type, directly linking coactivator activity to organismal physiology. In cancer, coactivator-dependent condensates can alter transcription and drive tumorigenesis, as shown for YAP fusion proteins in ependymoma.
• Defines the molecular function that converts DNA-binding transcription factor occupancy into increased transcription of specific gene sets.
• Explains how enhancers and super-enhancers achieve full gene activation through coactivator recruitment and cooperation.
• Provides a mechanistic framework for chromatin-based regulation, including histone modification and ATP-dependent remodeling.
• Links signal-dependent transcription factors to the basal RNA polymerase II machinery via bridging coactivators such as the Mediator complex.
• Underpins cell-type-specific gene expression programs and cellular identity.
• Is required for metabolic gene programs controlling mitochondrial biogenesis and respiration through PGC-1.
• Controls slow-twitch muscle fiber formation through PGC-1 alpha, with implications for exercise and metabolic health.
• Contributes to cancer when coactivator-driven condensates or fusions alter transcription, as in ependymoma.
• Can be systematically mapped using functional genomics screens for transcriptional activators in human cells.
• Provides a target class for CRISPR knockout, knock-in, and overexpression studies of gene regulation.
What Happens During transcription coactivator activity?
Recruitment to specific genomic loci
In simple terms: Coactivators do not find DNA on their own; they are brought to the right place by DNA-binding transcription factors.
Transcription coactivator activity begins when a DNA-binding transcription factor occupies a specific genomic locus and recruits a coactivator, either directly or through other coregulators. This recruitment is locus-specific and is the basis for the definition of GO:0003713, which requires binding to a DNA-binding transcription factor at a specific genomic locus. Super-enhancer studies show that classical enhancers and facilitators cooperate to recruit coactivators and fully activate gene expression. Functional screens in human cells have identified many transcriptional activators that are recruited to regulatory elements and are required for gene activation.
Chromatin modification and remodeling
In simple terms: Once recruited, coactivators can open up the chromatin so that transcription can proceed.
A major route for coactivator function is alteration of chromatin structure. One class of coactivators modifies chromatin through covalent modification of histones, while a second class remodels chromatin conformation in an ATP-dependent fashion. These activities increase accessibility of the locus to the basal transcription machinery and other coregulators. The Gene Ontology definition explicitly includes these chromatin-altering mechanisms as part of transcription coactivator activity.
Modulation of transcription factor-coregulator interactions
In simple terms: Some coactivators work by changing how transcription factors talk to other regulatory proteins.
A third class of coactivator activity modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. This can stabilize or destabilize coregulator complexes at a locus, thereby tuning the transcriptional output. Such modulation is part of the functional definition of GO:0003713 and helps explain how coactivators can act as signal integrators.
Bridging to the basal transcription machinery
In simple terms: Some coactivators act as a physical bridge between transcription factors and the machinery that reads genes.
A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex is the canonical example: it bridges sequence-specific DNA-binding transcription factors and RNA polymerase, and is therefore itself a transcription coactivator. This bridging function is essential for converting regulatory signals into productive transcription initiation.
Signal integration and condensate formation
In simple terms: Coactivators can cluster together into condensates that amplify gene activation signals.
Coactivator activity can be amplified through the formation of nuclear condensates that concentrate transcription factors and coactivators at specific loci. In ependymoma, nuclear condensates of YAP fusion proteins alter transcription to drive tumorigenesis, illustrating how coactivator-dependent condensation can reprogram gene expression. This condensate mechanism provides a physical explanation for how coactivators achieve robust, switch-like activation of specific gene sets.
Key Genes Involved in GO:0003713 transcription coactivator activity
The following genes and proteins are representative factors whose activities or complexes are directly relevant to transcription coactivator activity (GO:0003713) and its study in human cells and model systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPARGC1A (PGC-1 alpha) | Transcriptional coactivator that drives slow-twitch muscle fiber formation and mitochondrial programs | Metabolic and muscle biology; exercise physiology; mitochondrial disease models |
| PPARGC1A (PGC-1) | Thermogenic coactivator controlling mitochondrial biogenesis and respiration | Energy homeostasis; adaptive thermogenesis; metabolic disease research |
| MED1 | Subunit of the Mediator complex that bridges transcription factors and RNA polymerase | Core coactivator complex; enhancer function; cancer dependency studies |
| MED12 | Mediator subunit involved in transcriptional coactivation | Developmental disorders and cancer; Mediator complex assembly |
| EP300 (p300) | Histone acetyltransferase coactivator that modifies chromatin | Chromatin modification; enhancer activation; cancer epigenetics |
| CREBBP (CBP) | Histone acetyltransferase coactivator that modifies chromatin | Chromatin modification; developmental and cancer studies |
| NCOA1 (SRC-1) | Nuclear receptor coactivator that binds DNA-binding transcription factors | Androgen receptor signaling; hormone-dependent cancer models |
| NCOA2 (GRIP1) | Nuclear receptor coactivator modulating transcription factor-coregulator interactions | Nuclear receptor biology; metabolic and reproductive research |
| NCOA3 (AIB1) | Nuclear receptor coactivator implicated in transcription activation | Breast cancer and hormone signaling research |
| YAP1 | Transcriptional coactivator that forms nuclear condensates with fusion partners | Ependymoma tumorigenesis; condensate biology; fusion-driven cancers |
| TAZ (WWTR1) | Transcriptional coactivator related to YAP1 in Hippo pathway signaling | Hippo pathway; condensate formation; cancer models |
| GPR35 | G-protein coupled receptor linked to adipose tissue energy homeostasis and inflammation | Metabolic and inflammatory disease research; coactivator-related signaling |
| AR | DNA-binding transcription factor that recruits coactivators such as NCOA1 | Androgen signaling; prostate cancer; coactivator recruitment assays |
| ESR1 | DNA-binding transcription factor that recruits nuclear receptor coactivators | Breast cancer; endocrine resistance; coactivator dependency |
| TP53 | DNA-binding transcription factor that recruits coactivators to target genes | Tumor suppression; p53 target gene activation; cancer models |
| NF-kB (RELA) | DNA-binding transcription factor that recruits coactivators | Inflammation; immune signaling; coactivator-dependent transcription |
| SMARCA4 (BRG1) | ATP-dependent chromatin remodeler that can act in coactivator complexes | Chromatin remodeling; cancer; coactivator mechanism studies |
| KAT2A (GCN5) | Histone acetyltransferase coactivator that modifies chromatin | Chromatin modification; transcriptional activation research |
How Is transcription coactivator activity Regulated?
Transcription coactivator activity is regulated at multiple levels. Coactivators are recruited to specific loci by DNA-binding transcription factors in a signal-dependent manner, and their activity can be modulated by interactions with other coregulators. Post-translational modifications and complex assembly influence coactivator function, and the formation of nuclear condensates can concentrate coactivators to amplify transcription. Super-enhancer architecture, including classical enhancers and facilitators, regulates the recruitment and cooperation of coactivators to achieve full gene activation. In metabolic contexts, coactivators such as PGC-1 and PGC-1 alpha are regulated in response to physiological cues to control mitochondrial biogenesis and muscle fiber type. Systematic functional screens have also revealed that many transcriptional activators are required for cell fitness, indicating that coactivator activity is tightly regulated in human cells.
transcription coactivator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Ependymoma tumourigenesis driven by nuclear condensates of YAP fusion proteins | Knock-in of YAP fusion; condensate imaging; xenograft models |
| PPARGC1A (PGC-1 alpha) | Muscle fiber type and metabolic disease | Knockout and overexpression in muscle cells; exercise models |
| PPARGC1A (PGC-1) | Mitochondrial biogenesis and respiration disorders | Knockout in metabolic tissues; mitochondrial function assays |
| NCOA1 (SRC-1) | Androgen receptor-dependent cancer and hormone signaling | Point mutation of coactivator interface; reporter assays |
| GPR35 | Adipose tissue energy homeostasis and inflammation | Knockout and overexpression in adipocytes; metabolic phenotyping |
Cancer and fusion-driven tumorigenesis
Dysregulated transcription coactivator activity contributes to cancer through multiple mechanisms. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis, demonstrating how coactivator condensation can promote cancer. Nuclear receptor coactivators such as NCOA1 are recruited by the androgen receptor to activate specific gene sets, a process relevant to hormone-dependent cancers. Super-enhancer-driven coactivator recruitment can also sustain oncogenic gene expression programs, and functional screens have identified transcriptional activators required for cancer cell fitness.
Metabolic and energy homeostasis disorders
Coactivators control metabolic gene programs, and their dysfunction is linked to metabolic disease. PGC-1 is a thermogenic coactivator that controls mitochondrial biogenesis and respiration, making it central to energy homeostasis. PGC-1 alpha drives the formation of slow-twitch muscle fibres, linking coactivator activity to muscle metabolism and exercise adaptation. Kynurenic acid and GPR35 regulate adipose tissue energy homeostasis and inflammation, providing a signaling context in which coactivator-dependent transcription influences metabolic health.
Developmental and transcriptional regulatory disorders
Because coactivators are required for cell-type-specific gene expression programs, their disruption can cause developmental and transcriptional regulatory disorders. The Mediator complex bridges transcription factors and RNA polymerase, and mutations in Mediator subunits can impair transcription of specific gene sets. Chromatin-modifying coactivators such as histone acetyltransferases alter chromatin structure and modifications, and their dysfunction can perturb developmental gene regulation. Systematic characterization of human transcriptional activators provides a framework for understanding how coactivator dysfunction contributes to disease.
From transcription coactivator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate coactivator required for activation of a specific gene set? | CRISPR knockout cell line followed by RNA-seq and reporter assays |
| Does a point mutation in a coactivator alter transcription factor binding? | Point-mutation knock-in cell line with co-immunoprecipitation and ChIP |
| Can a coactivator fusion or condensate drive tumorigenesis? | Knock-in of fusion allele with condensate imaging and xenografts |
| Where does a coactivator bind across the genome? | Tagged knock-in with ChIP-seq or CUT&RUN |
| Does overexpression of a coactivator enhance a metabolic gene program? | Overexpression cell line with mitochondrial and metabolic assays |
| Which coactivators are essential for cell fitness? | CRISPR library screening with fitness readouts |
How to Study the transcription coactivator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in gene expression after coactivator perturbation | Identifying gene sets activated by a coactivator |
| ChIP-seq / CUT&RUN | Genomic binding of coactivators and transcription factors | Mapping coactivator recruitment to specific loci |
| Reporter assays | Activation strength of a candidate coactivator | Functional characterization of transcriptional activators |
| CRISPR library screening | Fitness or reporter output after gene knockout | Systematic discovery of coactivators |
| Co-immunoprecipitation | Physical interaction between coactivator and transcription factor | Testing coactivator recruitment interfaces |
| Live-cell imaging | Formation and dynamics of nuclear condensates | Studying condensate-driven transcription |
| Mitochondrial function assays | Respiration and biogenesis readouts | Testing PGC-1 coactivator function |
| Muscle fiber typing | Slow-twitch versus fast-twitch fiber composition | Testing PGC-1 alpha coactivator activity in muscle |
Transcriptional reporter and RNA-seq assays
Reporter assays and RNA-seq are used to measure whether a candidate coactivator increases transcription of specific gene sets. In human cells, functional characterization of transcriptional activators relies on reporter systems that quantify activation strength and specificity. RNA-seq after coactivator perturbation reveals the gene sets whose expression depends on the coactivator, directly testing the GO:0003713 definition of activating specific gene sets.
Chromatin and binding assays
ChIP-seq, CUT&RUN, and related methods map where coactivators and DNA-binding transcription factors occupy the genome. These assays test the requirement that coactivators bind DNA-binding transcription factors at specific genomic loci. Super-enhancer studies use chromatin assays to show how classical enhancers and facilitators cooperate to recruit coactivators and fully activate gene expression.
Functional genomics screens
CRISPR-based functional genomics screens identify transcriptional activators and coactivators required for gene activation or cell fitness. Such screens provide systematic evidence for coactivator activity across the human genome and help prioritize candidates for mechanistic studies. Screens can be combined with reporter readouts to directly link candidate genes to increased transcription of specific gene sets.
Imaging and condensate analysis
Advanced imaging is used to visualize nuclear condensates of coactivators and fusion proteins that alter transcription. In ependymoma, imaging of YAP fusion protein condensates revealed how they concentrate transcriptional machinery to drive tumorigenesis. These approaches complement biochemical assays by showing the spatial organization of coactivator-dependent transcription.
How CRISPR Can Be Used to Study GO:0003713 transcription coactivator activity
Knockout
CRISPR knockout is used to delete a candidate coactivator gene and test whether transcription of specific gene sets is lost. Knockout of coactivators followed by RNA-seq directly tests the requirement for the coactivator in activating target genes. In metabolic studies, knockout of PGC-1 or PGC-1 alpha can reveal defects in mitochondrial biogenesis, respiration, or muscle fiber type.
Point Mutation
Point-mutation knock-in can be used to disrupt specific coactivator interfaces, such as the surface that binds a DNA-binding transcription factor. Such models allow researchers to separate coactivator recruitment from other functions and to test the effect on transcription of specific gene sets. Point mutations in chromatin-modifying coactivators can also be used to dissect catalytic versus scaffolding functions.
Knock-in
Knock-in of tags, reporters, or fusion alleles enables precise tracking and functional analysis of coactivators. For example, knock-in of YAP fusion alleles has been used to model condensate-driven ependymoma tumorigenesis. Tagged knock-in of endogenous coactivators supports ChIP-seq, CUT&RUN, and imaging studies of locus-specific recruitment.
Overexpression
Overexpression of a coactivator can test whether increased coactivator levels are sufficient to enhance transcription of specific gene sets. Overexpression of PGC-1 alpha drives slow-twitch muscle fiber formation, demonstrating gain-of-function coactivator activity. Overexpression models are also useful for studying condensate formation and coactivator-driven oncogenic transcription.
How EDITGENE Supports transcription coactivator activity Research
Researchers studying transcription coactivator activity-related genes often need to determine whether a candidate gene is causally involved in activating specific gene sets, and CRISPR-based models provide the most direct way to test this. By combining knockout, point-mutation, knock-in, and overexpression strategies with functional genomics readouts, it is possible to move from correlation to mechanism for any coactivator of interest.
Contact EDITGENE today to design your custom CRISPR model for transcription coactivator activity research.
Frequently Asked Questions About transcription coactivator activity
What is transcription coactivator activity (GO:0003713)?
It is a transcription coregulator activity that activates or increases transcription of specific gene sets by binding DNA-binding transcription factors at specific genomic loci, either alone or as part of a complex.
What genes are involved in transcription coactivator activity?
Representative genes include PPARGC1A (PGC-1 and PGC-1 alpha), MED1, MED12, EP300, CREBBP, NCOA1, NCOA2, NCOA3, YAP1, and SMARCA4, among others.
How do transcription coactivators increase gene expression?
They can modify histones, remodel chromatin in an ATP-dependent manner, modulate transcription factor-coregulator interactions, or bridge transcription factors to the basal transcription machinery, including the Mediator complex.
What is the difference between a coactivator and a transcription factor?
A DNA-binding transcription factor recognizes specific DNA sequences, whereas a coactivator is recruited by that factor and increases transcription without sequence-specific DNA binding.
What is the Mediator complex in transcription coactivator activity?
The Mediator complex bridges sequence-specific DNA-binding transcription factors and RNA polymerase and is itself a transcription coactivator.
Which diseases are linked to transcription coactivator activity?
Coactivator dysfunction has been linked to cancer such as ependymoma, metabolic disorders involving PGC-1 and PGC-1 alpha, and developmental transcriptional regulatory disorders.
How can CRISPR be used to study transcription coactivator activity?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models can test whether a candidate coactivator is required or sufficient for activating specific gene sets.
What methods measure transcription coactivator activity?
RNA-seq, ChIP-seq, CUT&RUN, reporter assays, co-immunoprecipitation, CRISPR screens, and imaging of nuclear condensates are commonly used.
What is PGC-1 alpha and how does it relate to coactivator activity?
PGC-1 alpha is a transcriptional coactivator that drives the formation of slow-twitch muscle fibres and controls mitochondrial programs.
Why is transcription coactivator activity important for gene regulation?
It converts sequence-specific transcription factor occupancy into increased transcription of specific gene sets, shaping cell-type-specific expression programs and disease states.
Conclusion
Transcription coactivator activity (GO:0003713) is a central molecular function that explains how DNA-binding transcription factors increase expression of specific gene sets through chromatin modification, remodeling, coregulator modulation, and bridging to the basal transcription machinery. Its importance spans metabolic regulation, muscle physiology, and cancer, as illustrated by PGC-1, PGC-1 alpha, and YAP fusion condensates. Systematic functional characterization of human transcriptional activators continues to expand the list of coactivators and their target programs. For researchers, the key challenge is to establish causal links between a candidate coactivator and the gene sets it regulates. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with RNA-seq, chromatin assays, and imaging, provide a rigorous path from candidate gene to mechanism. EDITGENE supports this workflow with custom cell model generation, library screening, and bioinformatics services tailored to transcription coactivator activity research.
References
- 1. Sui X et al.. 1999. Specific androgen receptor activation by an artificial coactivator.. J Biol Chem 274(14):9449-54 PMID: 10092626
- 2. Blayney JW et al.. 2023. Super-enhancers include classical enhancers and facilitators to fully activate gene expression.. Cell 186(26):5826-5839.e18 PMID: 38101409
- 3. Alerasool N et al.. 2022. Identification and functional characterization of transcriptional activators in human cells.. Mol Cell 82(3):677-695.e7 PMID: 35016035
- 4. Agudelo LZ et al.. 2018. Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation.. Cell Metab 27(2):378-392.e5 PMID: 29414686
- 5. Wu Z et al.. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.. Cell 98(1):115-24 PMID: 10412986
- 6. Lin J et al.. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.. Nature 418(6899):797-801 PMID: 12181572
- 7. Hu X et al.. 2023. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis.. Nat Cell Biol 25(2):323-336 PMID: 36732631
- 8. Bylino OV et al.. 2020. Evolution of Regulated Transcription.. Cells 9(7) PMID: 32664620
